FOXP3 and neoplasm: Experiments detected a significant reduction of tumor-infiltrating FoxP3+ Treg and granulocytic MDSC (G-MDSCs) (vs. monocytic MDSC, M-MDSC) in mice receiving entinostat treatment (Kim et al., 2014; Christmas et al., 2018).